Martha S. Jordan

机构：Parker Institute for Cancer Immunotherapy, University of Pennsylvania · ORCID：0000-0003-2359-3227

发表论文 94 篇 · 总被引 8921 次 · h-index 36

代表论文

• Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells (2018 · Nature · 被引 879)
• Asymmetric Proteasome Segregation as a Mechanism for Unequal Partitioning of the Transcription Factor T-bet during T Lymphocyte Division (2011 · Immunity · 被引 197)
• The Loss of TET2 Promotes CD8+ T Cell Memory Differentiation (2017 · The Journal of Immunology · 被引 172)
• The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade (2022 · Immunity · 被引 102)
• The SWI/SNF chromatin remodeling complexes BAF and PBAF differentially regulate epigenetic transitions in exhausted CD8+ T cells (2023 · Immunity · 被引 84)
• Runx1 negatively regulates inflammatory cytokine production by neutrophils in response to Toll-like receptor signaling (2020 · Blood Advances · 被引 82)